Cleared Traditional

K913760 - PSORALITE , PHOTOTHERAPY TREATMENT EQUIPMENT

K913760 is an FDA 510(k) clearance for PSORALITE, manufactured by Psoralite Corp.. The device is a Class 2 General & Plastic Surgery device with product code FTC cleared through the Traditional 510(k) pathway after a 67-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1991
Decision
67d
Days
Class 2
Risk

K913760 is an FDA 510(k) clearance for the PSORALITE , PHOTOTHERAPY TREATMENT EQUIPMENT. Classified as Light, Ultraviolet, Dermatological (product code FTC), Class II - Special Controls.

Submitted by Psoralite Corp. (Columbia, US). The FDA issued a Cleared decision on October 28, 1991 after a review of 67 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4630 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Psoralite Corp. devices

FDA 510(k) Submission Details - K913760

510(k) Number K913760 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 1991
Decision Date October 28, 1991
Days to Decision 67 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 115d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FTC Device Classification - Class 2, Special Controls

Product Code FTC Light, Ultraviolet, Dermatological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTC Light, Ultraviolet, Dermatological

All 83
Devices cleared under the same product code (FTC) and FDA review panel - the closest regulatory comparables to K913760.
UVISOL AND UVISOL II
K934808 · National Biological Corp. · Dec 1993
PHOTOTHERAPY TIMER
K924969 · National Biological Corp. · Feb 1993
HANDISOL
K924077 · National Biological Corp. · Nov 1992
PANOSOL II UVA-218
K904426 · National Biological Corp. · Dec 1990
PANOSOL II UVB-206
K904427 · National Biological Corp. · Dec 1990
PANOSOL II UAB-228
K904428 · National Biological Corp. · Dec 1990